Your browser doesn't support javascript.
loading
Systematic characterization and comparison of the CYP2C9 variability of the Orang Asli in Malaysia with 12 populations.
Teh, Lay Kek; Subramaniam, Vinothini; Tuan Abdu Aziz, Tuan Azlin; Lee, Lian Shien; Ismail, Mohamed Izwan; Yu, Choo Yee; Ang, Geik Yong; James Johari, Richard; Ismet, Rose Iszati; Sahak, Noor Saadah; Ahmad, Aminuddin; Rahman, Thuhairah Abdul; Nor Ghazali, Fadzilah Mohd; Shaari, SyahrulAzlin; Omar, Mustaffa; Ismail, Adzrool Idzwan; Md Isa, Kamarudzaman; Salleh, Hood; Salleh, Mohd Zaki.
Affiliation
  • Teh LK; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia; Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Malaysia. Electronic address: tehlaykek2016@gmail.com.
  • Subramaniam V; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia.
  • Tuan Abdu Aziz TA; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia.
  • Lee LS; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia.
  • Ismail MI; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia.
  • Yu CY; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia.
  • Ang GY; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia.
  • James Johari R; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia; Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Malaysia.
  • Ismet RI; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia.
  • Sahak NS; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia.
  • Ahmad A; Faculty of Medicine, Universiti Teknologi MARA (UiTM), Malaysia.
  • Rahman TA; Faculty of Medicine, Universiti Teknologi MARA (UiTM), Malaysia.
  • Nor Ghazali FM; Faculty of Medicine, Universiti Teknologi MARA (UiTM), Malaysia.
  • Shaari S; Faculty of Medicine, Universiti Teknologi MARA (UiTM), Malaysia.
  • Omar M; Faculty of Social Sciences and Humanities, Universiti Kebangsaan Malaysia (UKM), Malaysia.
  • Ismail AI; Faculty of Art and Design (FSSR), Universiti Teknologi MARA (UiTM), Malaysia.
  • Md Isa K; Faculty of Communication and Media, University Selangor (Unisel), Malaysia.
  • Salleh H; Faculty of Social Sciences and Humanities, Universiti Kebangsaan Malaysia (UKM), Malaysia; Institut Alam Sekitar dan Pembangunan (LESTARI), Universiti Kebangsaan Malaysia (UKM), Malaysia.
  • Salleh MZ; Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA (UiTM), Malaysia; Faculty of Pharmacy, Universiti Teknologi MARA (UiTM), Malaysia. Electronic address: zakisalleh.mzs@gmail.com.
Drug Metab Pharmacokinet ; 31(4): 304-13, 2016 Aug.
Article in En | MEDLINE | ID: mdl-27325019
ABSTRACT
We conducted a systematic characterization of CYP2C9 variants in 61 Orang Asli and 96 Singaporean Malays using the whole genome sequences data and compared the variants with the other 11 HapMap populations. The frequency of rs1057910 (CYP2C9*3) is the highest in the Orang Asli compared to other populations. Three alleles with clinical implication were detected in the Orang Asli while 2 were found in the Singaporean Malays. Large numbers of the Orang Asli are predicted to have reduced metabolic capacity and therefore they would require a lower dose of drugs which are metabolized by CYP2C9. They are also at increased risks of adverse effects and therapeutic failures. A large number of CYP2C9 variants in the Orang Asli were not in the Hardy Weinberg Equilibrium which could be due to small sample size or mutations that disrupt the equilibrium of allele frequencies. In conclusion, different polymorphism patterns, allele frequencies, genotype frequencies and LD blocks are observed between the Orang Asli, the Singaporean Malays and the other populations. The study provided new information on the genetic polymorphism of CYP2C9 which is important for the implementation of precision medicine for the Orang Asli.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Single Nucleotide / Cytochrome P-450 CYP2C9 Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Drug Metab Pharmacokinet Journal subject: FARMACOLOGIA / METABOLISMO Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Single Nucleotide / Cytochrome P-450 CYP2C9 Type of study: Prognostic_studies Limits: Adult / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Drug Metab Pharmacokinet Journal subject: FARMACOLOGIA / METABOLISMO Year: 2016 Document type: Article